Literature DB >> 10961858

Multiple nonfunctional alleles of CCR5 are frequent in various human populations.

C Blanpain1, B Lee, M Tackoen, B Puffer, A Boom, F Libert, M Sharron, V Wittamer, G Vassart, R W Doms, M Parmentier.   

Abstract

CCR5 is the major coreceptor for macrophage-tropic strains of the human immunodeficiency virus type I (HIV-1). Homozygotes for a 32-base pair (bp) deletion in the coding sequence of the receptor (CCR5Delta32) were found to be highly resistant to viral infection, and CCR5 became, therefore, one of the paradigms illustrating the influence of genetic variability onto individual susceptibility to infectious and other diseases. We investigated the functional consequences of 16 other natural CCR5 mutations described in various human populations. We found that 10 of these variants are efficiently expressed at the cell surface, bind [(125)I]-MIP-1beta with affinities similar to wtCCR5, respond functionally to chemokines, and act as HIV-1 coreceptors. In addition to Delta32, six mutations were characterized by major alterations in their functional response to chemokines, as a consequence of intracellular trapping and poor expression at the cell surface (C101X, FS299), general or specific alteration of ligand binding affinities (C20S, C178R, A29S), or relative inability to mediate receptor activation (L55Q). A29S displayed an unusual pharmacological profile, binding and responding to MCP-2 similarly to wtCCR5, but exhibiting severely impaired binding and functional responses to MIP-1alpha, MIP-1beta, and RANTES. In addition to Delta32, only C101X was totally unable to mediate entry of HIV-1. The fact that nonfunctional CCR5 alleles are relatively frequent in various human populations reinforces the hypothesis of a selective pressure favoring these alleles. (Blood. 2000;96:1638-1645)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10961858

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  38 in total

1.  Pharmacological characterization of the chemokine receptor, CCR5.

Authors:  Anja Mueller; Nasir G Mahmoud; Marc C Goedecke; Jane A McKeating; Philip G Strange
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  A strong signature of balancing selection in the 5' cis-regulatory region of CCR5.

Authors:  Michael J Bamshad; Srinivas Mummidi; Enrique Gonzalez; Seema S Ahuja; Diane M Dunn; W Scott Watkins; Stephen Wooding; Anne C Stone; Lynn B Jorde; Robert B Weiss; Sunil K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

3.  A haplotype in the CCR5 gene promoter was associated with the susceptibility to HIV-1 infection in a northern Chinese population.

Authors:  Lidan Xu; Yuandong Qiao; Xuelong Zhang; Haiming Sun; Jingwei Wang; Donglin Sun; Xueyuan Jia; Chao Shen; Yanling Zhao; Yan Jin; Yang Yu; Hong Ling; Kaili Wang; Songbin Fu
Journal:  Mol Biol Rep       Date:  2010-04-04       Impact factor: 2.316

4.  TCR triggering transcriptionally downregulates CCR5 expression on rhesus macaque CD4(+) T-cells with no measurable effect on susceptibility to SIV infection.

Authors:  Jacob T Minang; Matthew T Trivett; Eugene V Barsov; Gregory Q Del Prete; Charles M Trubey; James A Thomas; Robert J Gorelick; Michael Piatak; David E Ott; Claes Ohlen
Journal:  Virology       Date:  2010-10-28       Impact factor: 3.616

5.  Pivotal role of the CCL5/CCR5 interaction for recruitment of endothelial progenitor cells in mouse wound healing.

Authors:  Yuko Ishida; Akihiko Kimura; Yumi Kuninaka; Masanori Inui; Kouji Matsushima; Naofumi Mukaida; Toshikazu Kondo
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

Review 6.  Evolution by gene loss.

Authors:  Ricard Albalat; Cristian Cañestro
Journal:  Nat Rev Genet       Date:  2016-04-18       Impact factor: 53.242

7.  Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5.

Authors:  H-F Dong; K Wigmore; M N Carrington; M Dean; J A Turpin; O M Z Howard
Journal:  Genes Immun       Date:  2005-10       Impact factor: 2.676

8.  Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly.

Authors:  Adriana Lima Vallochi; Anna Carla Goldberg; Angela Falcai; Rajendranath Ramasawmy; Jorge Kalil; Cláudio Silveira; Rubens Belfort; Luiz Vicente Rizzo
Journal:  Clin Ophthalmol       Date:  2008-12

9.  A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains.

Authors:  Samantha H Johnston; Michael A Lobritz; Sandra Nguyen; Kara Lassen; Shirley Delair; Filippo Posta; Yvonne J Bryson; Eric J Arts; Tom Chou; Benhur Lee
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

10.  The entry of entry inhibitors: a fusion of science and medicine.

Authors:  John P Moore; Robert W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.